| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | adherens junction | 4.24e-05 | 212 | 162 | 9 | GO:0005912 | |
| GeneOntologyCellularComponent | lamellipodium | 7.95e-05 | 230 | 162 | 9 | GO:0030027 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 9.76e-05 | 137 | 162 | 7 | GO:0019897 | |
| GeneOntologyCellularComponent | catenin complex | 1.06e-04 | 32 | 162 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | cell leading edge | ANK1 IQGAP2 SPTBN1 PABPC1 LDB2 CTNNA3 FER ROCK1 CTNNA1 CTNNA2 CTNNB1 USH2A CAPRIN1 | 1.46e-04 | 500 | 162 | 13 | GO:0031252 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 2.18e-04 | 263 | 162 | 9 | GO:0045111 | |
| GeneOntologyCellularComponent | intermediate filament | 4.03e-04 | 227 | 162 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 4.40e-04 | 230 | 162 | 8 | GO:0098562 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 4.40e-04 | 230 | 162 | 8 | GO:0019898 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 6.11e-04 | 185 | 162 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | keratin filament | 9.54e-04 | 97 | 162 | 5 | GO:0045095 | |
| GeneOntologyCellularComponent | apicolateral plasma membrane | 1.30e-03 | 28 | 162 | 3 | GO:0016327 | |
| GeneOntologyCellularComponent | desmosome | 1.30e-03 | 28 | 162 | 3 | GO:0030057 | |
| Domain | Alpha_catenin | 2.27e-06 | 4 | 156 | 3 | IPR001033 | |
| Domain | VINCULIN_1 | 2.27e-06 | 4 | 156 | 3 | PS00663 | |
| Domain | Vinculin_CS | 2.27e-06 | 4 | 156 | 3 | IPR000633 | |
| Domain | Vinculin | 5.65e-06 | 5 | 156 | 3 | PF01044 | |
| Domain | KRAB | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 ZNF229 ZNF708 ZNF630 ZNF728 ZNF81 ZNF333 ZNF730 | 1.00e-05 | 358 | 156 | 13 | PS50805 |
| Domain | KRAB | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 ZNF229 ZNF708 ZNF630 ZNF728 ZNF81 ZNF333 ZNF730 | 1.00e-05 | 358 | 156 | 13 | PF01352 |
| Domain | KRAB | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 ZNF229 ZNF708 ZNF630 ZNF728 ZNF81 ZNF333 ZNF730 | 1.38e-05 | 369 | 156 | 13 | SM00349 |
| Domain | KRAB | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 ZNF229 ZNF708 ZNF630 ZNF728 ZNF81 ZNF333 ZNF730 | 1.42e-05 | 370 | 156 | 13 | IPR001909 |
| Domain | ARM-like | TNPO1 DCAF1 STAG1 HUWE1 ARMCX2 TRRAP PKP3 CEP70 PUM3 CTNNB1 NIPBL | 1.72e-05 | 270 | 156 | 11 | IPR011989 |
| Domain | Vinculin/catenin | 1.95e-05 | 7 | 156 | 3 | IPR006077 | |
| Domain | Lsm6/sSmF | 6.93e-05 | 2 | 156 | 2 | IPR016487 | |
| Domain | ARM-type_fold | TNPO1 DCAF1 STAG1 HUWE1 ARMCX2 TRRAP UPF2 PKP3 PUM3 CTNNB1 NIPBL | 1.34e-04 | 339 | 156 | 11 | IPR016024 |
| Domain | Runt | 2.07e-04 | 3 | 156 | 2 | PF00853 | |
| Domain | RUNT | 2.07e-04 | 3 | 156 | 2 | PS51062 | |
| Domain | TF_Runt-rel_RUNX | 2.07e-04 | 3 | 156 | 2 | IPR016554 | |
| Domain | RunxI | 2.07e-04 | 3 | 156 | 2 | PF08504 | |
| Domain | Runt_dom | 2.07e-04 | 3 | 156 | 2 | IPR013524 | |
| Domain | RunxI_C_dom | 2.07e-04 | 3 | 156 | 2 | IPR013711 | |
| Domain | Runx_central_dom | 2.07e-04 | 3 | 156 | 2 | IPR027384 | |
| Domain | - | 2.07e-04 | 3 | 156 | 2 | 4.10.770.10 | |
| Domain | AML1_Runt | 2.07e-04 | 3 | 156 | 2 | IPR000040 | |
| Domain | Keratin_I | 4.90e-04 | 44 | 156 | 4 | IPR002957 | |
| Domain | - | 5.65e-04 | 222 | 156 | 8 | 1.25.10.10 | |
| Domain | - | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 IKZF1 ZNF229 ZNF708 ZNF630 ZNF728 ZNF511 ZNF81 ZNF333 ZNF730 | 5.77e-04 | 679 | 156 | 15 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 IKZF1 ZNF229 ZNF708 ZNF630 ZNF728 ZNF511 ZNF81 ZNF333 ZNF730 | 7.11e-04 | 693 | 156 | 15 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 IKZF1 ZNF229 ZNF708 ZNF630 ZNF728 ZNF511 ZNF81 ZNF333 ZNF730 | 7.22e-04 | 694 | 156 | 15 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 IKZF1 ZNF229 ZNF708 ZNF630 ZNF728 SCAPER ZNF511 ZNF81 ZNF333 ZNF730 | 7.83e-04 | 775 | 156 | 16 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 IKZF1 ZNF229 ZNF708 ZNF630 ZNF728 SCAPER ZNF511 ZNF81 ZNF333 ZNF730 | 8.04e-04 | 777 | 156 | 16 | PS00028 |
| Domain | p53/RUNT-type_TF_DNA-bd | 1.02e-03 | 6 | 156 | 2 | IPR012346 | |
| Domain | - | 1.02e-03 | 6 | 156 | 2 | 2.60.40.720 | |
| Domain | Znf_C2H2-like | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 IKZF1 ZNF229 ZNF708 ZNF630 ZNF728 SCAPER ZNF511 ZNF81 ZNF333 ZNF730 | 1.04e-03 | 796 | 156 | 16 | IPR015880 |
| Domain | Znf_C2H2 | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 IKZF1 ZNF229 ZNF708 ZNF630 ZNF728 SCAPER ZNF511 ZNF81 ZNF333 ZNF730 | 1.17e-03 | 805 | 156 | 16 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 IKZF1 ZNF229 ZNF708 ZNF630 ZNF728 SCAPER ZNF511 ZNF81 ZNF333 ZNF730 | 1.21e-03 | 808 | 156 | 16 | SM00355 |
| Domain | zf-C2H2_6 | ZNF729 ZNF486 ZNF316 ZNF429 ZNF208 ZNF229 ZNF728 ZNF333 ZNF730 | 1.32e-03 | 314 | 156 | 9 | PF13912 |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 3.23e-06 | 12 | 130 | 4 | M12851 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 5.62e-05 | 73 | 130 | 6 | M638 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 6.18e-05 | 9 | 130 | 3 | MM1366 | |
| Pubmed | 4.54e-10 | 4 | 162 | 4 | 18775424 | ||
| Pubmed | TNPO1 UBR2 KRT18 SPTBN1 COPB2 TFIP11 HMGCS1 HUWE1 RUNX2 RUNX1 PABPC1 MEX3C DNAH1 AKAP9 FDPS PKP3 CSNK2B CGN ZNF511 AFF1 CTNNA1 CTNNB1 SNRPF CAPRIN1 | 4.16e-09 | 1247 | 162 | 24 | 27684187 | |
| Pubmed | 1.57e-08 | 7 | 162 | 4 | 17535849 | ||
| Pubmed | Adhesion protein VSIG1 is required for the proper differentiation of glandular gastric epithelia. | 1.57e-08 | 7 | 162 | 4 | 21991385 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 DCAF1 RNF31 KRT18 RASA3 PLEKHG4 SMCHD1 SPTBN1 COPB2 TFIP11 HUWE1 RUNX1 TRRAP PABPC1 LGALS1 BLM ACSL4 UPF2 FDPS CSNK2B PUM3 CAPRIN1 NIPBL PCMT1 | 1.98e-08 | 1353 | 162 | 24 | 29467282 |
| Pubmed | Functional analysis of ectodermal β-catenin during external genitalia formation. | 3.13e-08 | 8 | 162 | 4 | 23480356 | |
| Pubmed | 3.13e-08 | 8 | 162 | 4 | 7626889 | ||
| Pubmed | Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. | 3.95e-08 | 21 | 162 | 5 | 19129494 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TNPO1 EPPK1 KRT16 KRT18 SMCHD1 ANXA11 CEP290 LAMB2 HUWE1 TRRAP PABPC1 NRP1 PKP3 CSNK2B CGN PUM3 CTNNA1 CTNNB1 NIPBL PCMT1 | 7.23e-08 | 1024 | 162 | 20 | 24711643 |
| Pubmed | TNPO1 EPPK1 SMCHD1 ANXA11 SPTBN1 COPB2 NSD1 HUWE1 TRRAP PABPC1 BLM CGN PUM3 CTNNA1 CAPRIN1 NIPBL | 7.90e-08 | 653 | 162 | 16 | 22586326 | |
| Pubmed | Structure of the dimerization and beta-catenin-binding region of alpha-catenin. | 9.92e-08 | 3 | 162 | 3 | 10882138 | |
| Pubmed | Leucine zipper domain of HIV-1 gp41 interacted specifically with alpha-catenin. | 9.92e-08 | 3 | 162 | 3 | 11883950 | |
| Pubmed | The cytoplasmic domain of HIV-1 gp41 interacts with the carboxyl-terminal region of alpha-catenin. | 9.92e-08 | 3 | 162 | 3 | 10420987 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCOA2 UBR2 STAG1 IQGAP2 PLEKHG4 PARP2 COPB2 HUWE1 TRRAP LDB2 BLM ACSL4 RINT1 UBP1 LRP1 CTNNB1 CABIN1 PRPF39 | 1.18e-07 | 857 | 162 | 18 | 25609649 |
| Pubmed | Epidermal development requires ninein for spindle orientation and cortical microtubule organization. | 1.25e-07 | 26 | 162 | 5 | 30923192 | |
| Pubmed | STARD13 NPR1 STAG1 INPP4A SPTBN1 OTUB1 LAMB2 HUWE1 RYR2 LDB2 LRP1 AFF1 ROCK1 CHD6 CTNNB1 | 1.31e-07 | 591 | 162 | 15 | 15231748 | |
| Pubmed | 1.46e-07 | 11 | 162 | 4 | 14657280 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 6188955 | ||
| Pubmed | N-cadherin mediates cortical organization in the mouse brain. | 3.95e-07 | 4 | 162 | 3 | 17222817 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 UBR2 TCHP RASA3 ZC3H8 INPP4A RNF213 ATP8B1 HUWE1 PDE10A TRRAP PDXK DNAH1 NRP1 ZNF708 PACS1 PKP3 LMLN TTC21B LRP1 AFF1 CHD6 TNFAIP8 | 4.67e-07 | 1489 | 162 | 23 | 28611215 |
| Pubmed | UBR2 KRT16 KRT18 SPTBN1 CEP290 COPB2 CCDC18 RNF213 HUWE1 PPEF1 BLM ACSL4 PACS1 RINT1 AKAP9 CGN ROCK1 DUSP10 CTNNA1 | 4.93e-07 | 1049 | 162 | 19 | 27880917 | |
| Pubmed | Differential expression of alpha-E-catenin and alpha-N-catenin in the developing cerebral cortex. | 9.85e-07 | 5 | 162 | 3 | 16457793 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 23136403 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 2788574 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 2349235 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 7925023 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 12551949 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 16325583 | ||
| Pubmed | TNPO1 KRT18 IQGAP2 PARP2 SPTBN1 OTUB1 COPB2 RNF213 FASTKD5 HUWE1 PDXK RINT1 FDPS CSNK2B PUM3 CTNNA1 CTNNA2 CTNNB1 CABIN1 SNRPF CAPRIN1 ALPL | 1.02e-06 | 1440 | 162 | 22 | 30833792 | |
| Pubmed | 1.03e-06 | 17 | 162 | 4 | 11781569 | ||
| Pubmed | NCOA2 UBR2 EPPK1 RNF31 ZC3H8 PARP2 ZNF316 KNOP1 BLM UBP1 SCOC PUM3 CTNNA1 | 1.45e-06 | 533 | 162 | 13 | 25544563 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TNPO1 EPPK1 KRT18 ANXA11 SPTBN1 OTUB1 COPB2 RNF213 HMGCS1 HUWE1 PABPC1 LGALS1 GSS ACSL4 CHMP7 CSNK2B LRP1 ROCK1 CTNNA1 CTNNB1 PCMT1 | 1.68e-06 | 1367 | 162 | 21 | 32687490 |
| Pubmed | Cadherin-dependent adhesion is required for muscle stem cell niche anchorage and maintenance. | 1.96e-06 | 6 | 162 | 3 | 38456551 | |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 16185771 | ||
| Pubmed | Requirement for N-cadherin-catenin complex in heart development. | 1.96e-06 | 6 | 162 | 3 | 21680756 | |
| Pubmed | 1.96e-06 | 6 | 162 | 3 | 12975353 | ||
| Pubmed | 2.30e-06 | 181 | 162 | 8 | 37372979 | ||
| Pubmed | NCOA2 IQGAP2 SPTBN1 NSD1 HUWE1 PABPC1 LDB2 WDR91 AKAP9 LRP1 ROCK1 CTNNA1 CTNNA2 CTNNB1 CABIN1 CAPRIN1 NIPBL | 2.89e-06 | 963 | 162 | 17 | 28671696 | |
| Pubmed | Modulation of apical constriction by Wnt signaling is required for lung epithelial shape transition. | 3.11e-06 | 22 | 162 | 4 | 27913639 | |
| Pubmed | 3.11e-06 | 22 | 162 | 4 | 9811459 | ||
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 12808048 | ||
| Pubmed | Expression and cell membrane localization of catenins during mouse preimplantation development. | 3.42e-06 | 7 | 162 | 3 | 8853988 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 9837810 | ||
| Pubmed | The cell adhesion molecule M-cadherin is not essential for muscle development and regeneration. | 3.42e-06 | 7 | 162 | 3 | 12052883 | |
| Pubmed | 3.42e-06 | 7 | 162 | 3 | 18397997 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TNPO1 EPPK1 STAG1 SMCHD1 ANXA11 SPTBN1 COPB2 HUWE1 BLM NDC80 PKP3 CTNNA1 NIPBL | 3.78e-06 | 582 | 162 | 13 | 20467437 |
| Pubmed | STARD13 KRT10 KRT16 STAG1 KRT18 IQGAP2 SMCHD1 ABCB5 SPTBN1 PDE10A MINDY2 PABPC1 RYR2 KNOP1 ACSL4 RINT1 FAM186A LMLN CHD6 TNFAIP8 NIPBL | 3.87e-06 | 1442 | 162 | 21 | 35575683 | |
| Pubmed | TNPO1 UBR2 KRT18 SPTBN1 COPB2 PABPC1 BLM CTNNA1 CTNNB1 PRPF39 CAPRIN1 PCMT1 | 3.88e-06 | 494 | 162 | 12 | 26831064 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | TNPO1 DCAF1 KRT18 ZC3H8 SMCHD1 PARP2 OTUB1 TFIP11 HUWE1 LGALS1 BLM CSNK2B PUM3 CTNNB1 SNRPF CAPRIN1 PCMT1 | 4.11e-06 | 989 | 162 | 17 | 36424410 |
| Pubmed | NCOA2 SMCHD1 OTUB1 ZNF316 IKZF1 HMGCS1 RUNX2 RUNX1 TRRAP PABPC1 LSM6 FDPS PUM3 PRPF39 SNRPF CAPRIN1 NIPBL PCMT1 | 4.32e-06 | 1103 | 162 | 18 | 34189442 | |
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 12640114 | ||
| Pubmed | Identification of trichoplein, a novel keratin filament-binding protein. | 5.46e-06 | 8 | 162 | 3 | 15731013 | |
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 12068957 | ||
| Pubmed | 5.46e-06 | 8 | 162 | 3 | 11321598 | ||
| Pubmed | 5.71e-06 | 272 | 162 | 9 | 31010829 | ||
| Pubmed | 5.98e-06 | 206 | 162 | 8 | 22174317 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KRT10 STAG1 ARHGEF5 SMCHD1 NSD1 TRRAP KNOP1 BLM CSNK2B PUM3 CHD6 CABIN1 NIPBL | 6.05e-06 | 608 | 162 | 13 | 36089195 |
| Pubmed | αE-Catenin Is a Positive Regulator of Pancreatic Islet Cell Lineage Differentiation. | 6.26e-06 | 26 | 162 | 4 | 28793255 | |
| Pubmed | IQGAP2 SMCHD1 SPTBN1 TFIP11 PABPC1 MEX3C KNOP1 NRP1 ACSL4 C3P1 AKAP9 UPF2 CSNK2B CGN PUM3 CTNNA2 CTNNB1 PRPF39 SNRPF CAPRIN1 | 6.54e-06 | 1371 | 162 | 20 | 36244648 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TNPO1 KRT10 EPPK1 KRT16 KRT18 SMCHD1 PARP2 SPTBN1 PABPC1 LGALS1 KNOP1 UPF2 PKP3 CGN PUM3 CTNNA1 CTNNB1 SNRPF CAPRIN1 | 6.88e-06 | 1257 | 162 | 19 | 36526897 |
| Pubmed | 7.67e-06 | 152 | 162 | 7 | 34299191 | ||
| Pubmed | KRT26 KRT10 KRT16 KRT18 ZC3H8 COPB2 E2F7 PABPC1 AK7 LSM6 CSNK2B ZNF511 AFF1 CHD6 SNRPF CAPRIN1 EPB42 PCMT1 | 7.91e-06 | 1153 | 162 | 18 | 29845934 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF1 NPR1 STAG1 COPB2 TFIP11 PABPC1 LGALS1 STN1 BLM PACS1 RINT1 NDC80 GNAT3 CTNNA1 SNRPF CAPRIN1 NIPBL PCMT1 | 8.10e-06 | 1155 | 162 | 18 | 20360068 |
| Pubmed | Switching of α-Catenin From Epithelial to Neuronal Type During Lens Epithelial Cell Differentiation. | 8.16e-06 | 9 | 162 | 3 | 28692740 | |
| Pubmed | Expression of catenins during mouse embryonic development and in adult tissues. | 8.16e-06 | 9 | 162 | 3 | 8821035 | |
| Pubmed | NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. | 8.16e-06 | 9 | 162 | 3 | 12695331 | |
| Pubmed | 1.03e-05 | 159 | 162 | 7 | 34537242 | ||
| Pubmed | 1.13e-05 | 30 | 162 | 4 | 34905516 | ||
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 27151949 | ||
| Pubmed | Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo. | 1.16e-05 | 10 | 162 | 3 | 21924256 | |
| Pubmed | Spatiotemporal expression pattern of keratins in skin of AP-2alpha-deficient mice. | 1.16e-05 | 10 | 162 | 3 | 10571739 | |
| Pubmed | Lima1 mediates the pluripotency control of membrane dynamics and cellular metabolism. | 1.16e-05 | 10 | 162 | 3 | 35105859 | |
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 14517306 | ||
| Pubmed | Functional consequences of necdin nucleocytoplasmic localization. | 1.26e-05 | 64 | 162 | 5 | 22442722 | |
| Pubmed | SMCHD1 CEP290 HUWE1 ARMCX2 IQCD TRRAP KNOP1 CSNK2B CHD6 CTNNA1 CTNNB1 | 1.37e-05 | 469 | 162 | 11 | 27634302 | |
| Pubmed | 1.59e-05 | 11 | 162 | 3 | 16466397 | ||
| Pubmed | Lis1 is essential for cortical microtubule organization and desmosome stability in the epidermis. | 1.59e-05 | 11 | 162 | 3 | 21844209 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | KRT10 EPPK1 KRT16 KRT18 SPTBN1 PABPC1 LGALS1 ACSL4 PKP3 CAPRIN1 PCMT1 ALPL | 1.93e-05 | 580 | 162 | 12 | 35676659 |
| Pubmed | 2.12e-05 | 12 | 162 | 3 | 26929452 | ||
| Pubmed | Role of GSK-3β in the osteogenic differentiation of palatal mesenchyme. | 2.12e-05 | 12 | 162 | 3 | 22022457 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 9233771 | ||
| Pubmed | Dysregulation of NIPBL leads to impaired RUNX1 expression and haematopoietic defects. | 2.16e-05 | 2 | 162 | 2 | 32323916 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15731014 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15731018 | ||
| Pubmed | Mammalian BLM helicase is critical for integrating multiple pathways of meiotic recombination. | 2.16e-05 | 2 | 162 | 2 | 20308424 | |
| Pubmed | Assembly of the cadherin-catenin complex in vitro with recombinant proteins. | 2.16e-05 | 2 | 162 | 2 | 7706414 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15695815 | ||
| Pubmed | Management of atypical pneumonias in view of the new entity "Legionnaire's disease". | 2.16e-05 | 2 | 162 | 2 | 276901 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 32535615 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 17542994 | ||
| Pubmed | Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. | 2.16e-05 | 2 | 162 | 2 | 16059634 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 24100690 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 32180230 | ||
| Pubmed | Nuclear α-catenin mediates the DNA damage response via β-catenin and nuclear actin. | 2.16e-05 | 2 | 162 | 2 | 28348105 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 17290219 | ||
| Pubmed | αE-catenin is an autoinhibited molecule that coactivates vinculin. | 2.16e-05 | 2 | 162 | 2 | 22586082 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 8555428 | ||
| Pubmed | Lipid-binding role of betaII-spectrin ankyrin-binding domain. | 2.16e-05 | 2 | 162 | 2 | 17716929 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 32035618 | ||
| Pubmed | Monomeric α-catenin links cadherin to the actin cytoskeleton. | 2.16e-05 | 2 | 162 | 2 | 23417122 | |
| Interaction | KRT18 interactions | KRT10 EPPK1 KRT16 RNF31 KRT18 TCHP SMCHD1 CEP290 CCDC18 FASTKD5 HMGCS1 HUWE1 PABPC1 UPF2 FDPS PKP3 CTNNA1 USH2A | 4.47e-09 | 419 | 156 | 18 | int:KRT18 |
| Interaction | TRIM28 interactions | DCAF1 EPPK1 ZNF486 RNF31 STAG1 IQGAP2 PARP2 ANXA11 OTUB1 COPB2 ZNF316 ZNF208 IKZF1 HUWE1 ZNF229 TRRAP PABPC1 MEX3C ZNF708 UPF2 UBP1 ZNF728 FDPS ZNF724 PUM3 ZNF81 CTNNB1 ZNF333 PRPF39 NIPBL | 8.98e-07 | 1474 | 156 | 30 | int:TRIM28 |
| Interaction | HERC2 interactions | INPP4A ARHGEF5 SPTBN1 CEP290 COPB2 NSD1 FASTKD5 TFIP11 PABPC1 KNOP1 BLM AKAP9 NDC80 CTNNA1 CTNNB1 CCDC136 | 1.91e-06 | 503 | 156 | 16 | int:HERC2 |
| Interaction | CCDC146 interactions | 3.40e-06 | 82 | 156 | 7 | int:CCDC146 | |
| Interaction | SYCE1 interactions | 6.62e-06 | 127 | 156 | 8 | int:SYCE1 | |
| Interaction | CDH12 interactions | 7.60e-06 | 17 | 156 | 4 | int:CDH12 | |
| Interaction | HDAC4 interactions | STARD13 STAG1 INPP4A SMCHD1 SPTBN1 TFIP11 IKZF1 HUWE1 RUNX2 RINT1 UBP1 CGN CEP70 FER UNK CHD6 CTNNB1 CCDC136 | 1.89e-05 | 744 | 156 | 18 | int:HDAC4 |
| Interaction | SNW1 interactions | NCOA2 EPPK1 STAG1 SMCHD1 SPTBN1 TFIP11 IKZF1 HUWE1 RUNX2 PABPC1 BLM ATP1B4 RINT1 NDC80 PKP3 CEP70 SNRPF NIPBL | 2.00e-05 | 747 | 156 | 18 | int:SNW1 |
| Interaction | CCDC187 interactions | 2.73e-05 | 76 | 156 | 6 | int:CCDC187 | |
| Interaction | RNF6 interactions | 2.73e-05 | 76 | 156 | 6 | int:RNF6 | |
| Interaction | KRT6A interactions | 3.55e-05 | 160 | 156 | 8 | int:KRT6A | |
| Interaction | KRT8 interactions | KRT26 KRT10 EPPK1 KRT16 RNF31 KRT18 TCHP CCDC18 TFIP11 ZNF708 AKAP9 NDC80 UNK | 4.05e-05 | 441 | 156 | 13 | int:KRT8 |
| Interaction | WDR76 interactions | EPPK1 KRT18 SMCHD1 PARP2 SPTBN1 LAMB2 IKZF1 RUNX1 TRRAP CSNK2B LRP1 CTNNA1 | 4.51e-05 | 383 | 156 | 12 | int:WDR76 |
| Interaction | CCDC8 interactions | TNPO1 EPPK1 KRT16 KRT18 SMCHD1 ANXA11 CEP290 LAMB2 HUWE1 PABPC1 NRP1 PKP3 CGN CTNNA1 CTNNB1 NIPBL | 5.14e-05 | 656 | 156 | 16 | int:CCDC8 |
| Interaction | PEX5L interactions | 6.07e-05 | 54 | 156 | 5 | int:PEX5L | |
| Interaction | SIRT7 interactions | TNPO1 DCAF1 EPPK1 SMCHD1 ANXA11 SPTBN1 COPB2 NSD1 HUWE1 TRRAP PABPC1 BLM CGN PUM3 CTNNA1 CAPRIN1 NIPBL | 6.65e-05 | 744 | 156 | 17 | int:SIRT7 |
| Interaction | KRT19 interactions | KRT10 KRT16 RNF31 KRT18 TCHP CEP290 CCDC18 AKAP9 NDC80 CTNNB1 | 7.15e-05 | 282 | 156 | 10 | int:KRT19 |
| Interaction | AR interactions | TNPO1 NCOA2 EPPK1 RNF31 EFCAB6 KRT18 SMCHD1 OTUB1 NSD1 RNF213 HUWE1 RUNX2 RUNX1 TRRAP PABPC1 CSNK2B CGN CTNNA1 CTNNB1 NIPBL | 8.40e-05 | 992 | 156 | 20 | int:AR |
| Interaction | KRT75 interactions | 8.49e-05 | 181 | 156 | 8 | int:KRT75 | |
| Interaction | KRT72 interactions | 9.31e-05 | 59 | 156 | 5 | int:KRT72 | |
| Interaction | BRCA1 interactions | TNPO1 NCOA2 UBR2 STAG1 KRT18 SMCHD1 SPTBN1 COPB2 HUWE1 RUNX1 PABPC1 STN1 BLM ACSL4 CSNK2B CTNNA1 CTNNB1 CABIN1 PRPF39 USH2A CAPRIN1 NIPBL PCMT1 | 9.41e-05 | 1249 | 156 | 23 | int:BRCA1 |
| Interaction | CDH10 interactions | 9.51e-05 | 12 | 156 | 3 | int:CDH10 | |
| Interaction | COIL interactions | TNPO1 PLEKHG4 NSD1 FASTKD5 KNOP1 BLM LSM6 CSNK2B CEP70 CHD6 MPND SNRPF NIPBL CCDC136 | 1.03e-04 | 552 | 156 | 14 | int:COIL |
| Interaction | PCNT interactions | 1.12e-04 | 241 | 156 | 9 | int:PCNT | |
| Interaction | EED interactions | TNPO1 DCAF1 KRT10 STAG1 KRT18 SMCHD1 SPTBN1 CEP290 OTUB1 COPB2 NSD1 TFIP11 HUWE1 TRRAP PABPC1 LGALS1 ACSL4 PKP3 CGN TTC21B PUM3 CTNNA1 CTNNB1 SNRPF NIPBL | 1.22e-04 | 1445 | 156 | 25 | int:EED |
| Interaction | MAB21L2 interactions | 1.26e-04 | 143 | 156 | 7 | int:MAB21L2 | |
| Interaction | TSG101 interactions | KRT16 RNF31 KRT18 SMCHD1 TFIP11 PABPC1 AKAP9 FDPS ROCK1 CAPRIN1 | 1.29e-04 | 303 | 156 | 10 | int:TSG101 |
| Interaction | AP2M1 interactions | DCAF1 KRT10 KRT16 SPTBN1 IKZF1 HUWE1 REXO1 MEX3C KNOP1 NRP1 CSNK2B CTNNB1 | 1.35e-04 | 430 | 156 | 12 | int:AP2M1 |
| Interaction | NDC80 interactions | TCHP CEP290 CCDC18 TFIP11 RUNX1 AKAP9 NDC80 ROCK1 CCDC136 RUFY4 | 1.64e-04 | 312 | 156 | 10 | int:NDC80 |
| Interaction | PRPF31 interactions | STAG1 PLEKHG4 TFIP11 RINT1 LSM6 UPF2 TTC21B CEP70 SNRPF NIPBL CCDC136 | 1.64e-04 | 374 | 156 | 11 | int:PRPF31 |
| Interaction | LATS1 interactions | DCAF1 KRT16 TCHP SPTBN1 CEP290 CCDC18 E2F7 TFIP11 AKAP9 CGN CEP70 TNFAIP8 | 1.67e-04 | 440 | 156 | 12 | int:LATS1 |
| Interaction | LSP1P3 interactions | 1.78e-04 | 3 | 156 | 2 | int:LSP1P3 | |
| Interaction | SFR1 interactions | 1.87e-04 | 37 | 156 | 4 | int:SFR1 | |
| Interaction | H3-4 interactions | TNPO1 DCAF1 NCOA2 ZC3H8 PARP2 CEP290 NSD1 IQCD TRRAP REXO1 AFF1 CHD6 | 1.97e-04 | 448 | 156 | 12 | int:H3-4 |
| Interaction | FAM161A interactions | 2.16e-04 | 156 | 156 | 7 | int:FAM161A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 1.38e-08 | 122 | 162 | 8 | chr19p12 | |
| Cytoband | 19p12 | 3.49e-08 | 90 | 162 | 7 | 19p12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF729 ZNF777 ZNF486 ZNF316 ZNF429 ZNF208 IKZF1 ZNF229 ZNF708 ZNF630 ZNF728 SCAPER ZNF511 ZNF81 ZNF333 ZNF730 | 6.17e-06 | 718 | 109 | 16 | 28 |
| GeneFamily | Keratins, type I | 2.29e-05 | 28 | 109 | 4 | 608 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | TNPO1 NCOA2 MICAL1 SMCHD1 ANXA11 SPTBN1 OTUB1 PDE10A TRRAP LGALS1 PDXK MEX3C GSS KNOP1 AKAP9 LRP1 PUM3 TNFAIP8 PCMT1 | 4.30e-07 | 790 | 161 | 19 | M12490 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STARD13 NCOA2 UBR2 STAG1 SMCHD1 ATP8B1 RUNX1 TRRAP BLM ACSL4 AKAP9 UPF2 NDC80 AFF1 ROCK1 PUM3 TNFAIP8 NIPBL PCMT1 | 1.42e-06 | 856 | 161 | 19 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | STARD13 UBR2 STAG1 SMCHD1 RUNX1 TRRAP BLM AKAP9 UPF2 NDC80 AFF1 PUM3 PCMT1 | 6.59e-06 | 466 | 161 | 13 | M13522 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TNPO1 ZNF486 IQGAP2 ZC3H8 SMCHD1 CEP290 BLM RINT1 NDC80 SCOC CEP70 FER PUM3 PRPF39 NIPBL | 1.37e-05 | 656 | 161 | 15 | M18979 |
| Coexpression | DELYS_THYROID_CANCER_DN | 1.47e-05 | 233 | 161 | 9 | M13273 | |
| Coexpression | GSE22886_TH1_VS_TH2_12H_ACT_DN | 3.11e-05 | 197 | 161 | 8 | M4509 | |
| Coexpression | GSE27786_NKTCELL_VS_NEUTROPHIL_UP | 3.46e-05 | 200 | 161 | 8 | M4868 | |
| Coexpression | GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP | 3.46e-05 | 200 | 161 | 8 | M8221 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | SMCHD1 CEP290 RNF213 ZNF229 RUNX1 PDE10A AK7 RYR2 SERPINI1 ROCK1 | 1.01e-05 | 233 | 158 | 10 | gudmap_developingGonad_e12.5_ovary_k5_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZNF729 EFCAB6 CCDC18 IKZF1 PDE10A RINT1 HPD ZNF728 PLCH2 CEP70 ROCK1 SLC2A13 | 1.64e-05 | 359 | 158 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#3_top-relative-expression-ranked_500 | 2.21e-05 | 113 | 158 | 7 | gudmap_developingGonad_e16.5_ovary_500_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_100 | 3.88e-05 | 26 | 158 | 4 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.98e-05 | 219 | 158 | 9 | gudmap_developingGonad_e16.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.99e-05 | 179 | 158 | 8 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_500 | 6.11e-05 | 91 | 158 | 6 | gudmap_developingGonad_e14.5_ ovary_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ZNF729 NCOA2 UBR2 MICAL1 RNF31 CEP290 HUWE1 STN1 ACSL4 RINT1 AIFM2 AKAP9 ZNF728 CEP70 ROCK1 SLC2A13 NIPBL | 7.38e-05 | 780 | 158 | 17 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_200 | 8.40e-05 | 60 | 158 | 5 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | DCAF1 EFCAB6 CEP290 CCDC18 RNF213 IKZF1 BLOC1S1 RUNX2 BLM WDR91 AIFM2 AKAP9 UBP1 PLCH2 CEP70 ROCK1 TNFAIP8 NIPBL PCMT1 | 1.45e-04 | 989 | 158 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.49e-04 | 204 | 158 | 8 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200 | 1.84e-04 | 158 | 158 | 7 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.68e-04 | 168 | 158 | 7 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | 2.99e-04 | 171 | 158 | 7 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | EFCAB6 CEP290 CCDC18 RNF213 IKZF1 RUNX2 AIFM2 AKAP9 PLCH2 CEP70 ROCK1 TNFAIP8 | 3.25e-04 | 492 | 158 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | ANK1 CEP290 CCDC18 AIFM2 AKAP9 HPD UBP1 FDPS PLCH2 CEP70 ROCK1 PRPF39 | 3.25e-04 | 492 | 158 | 12 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | ANK1 EFCAB6 CEP290 BLOC1S1 ACSL4 AIFM2 AKAP9 HPD FDPS CEP70 ROCK1 NIPBL | 3.25e-04 | 492 | 158 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.45e-04 | 231 | 158 | 8 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 3.48e-04 | 81 | 158 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_500 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.50e-07 | 197 | 162 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.02e-07 | 199 | 162 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.47e-06 | 186 | 162 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 5.67e-06 | 187 | 162 | 7 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-06 | 187 | 162 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | facs-BAT-Fat-24m-Epithelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-06 | 189 | 162 | 7 | 8e89365949b19e34b7dd4125b59db1c5ffb8340b | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 6.29e-06 | 190 | 162 | 7 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.51e-06 | 191 | 162 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.46e-06 | 195 | 162 | 7 | eb104f3bb08ab9eca31273c0523a5c90de1f30a9 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 7.46e-06 | 195 | 162 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-06 | 198 | 162 | 7 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-06 | 198 | 162 | 7 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.79e-06 | 200 | 162 | 7 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 139 | 162 | 6 | aefcfda2b2db302ce4b3d2a09f767be0b1c3ac6c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 139 | 162 | 6 | b9c2dfab119ac0efdf931bb2910e82bccdb4e48d | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-05 | 165 | 162 | 6 | cdc05f4a3c2c301f537ae641314875e5ecc16510 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-05 | 165 | 162 | 6 | 567c9f8fe29b5d34c2e39d9a17db54eba51ee559 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-05 | 165 | 162 | 6 | 2ebabe6fdbcf8765bcf9d98faf20da783c9d113d | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-05 | 167 | 162 | 6 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Th17|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 168 | 162 | 6 | 97bf074b91c9ae0064edc31fa4a2658ffdcfefa3 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.62e-05 | 169 | 162 | 6 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-05 | 170 | 162 | 6 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 4.00e-05 | 172 | 162 | 6 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-05 | 173 | 162 | 6 | 5c55e1e27e9e3e77600d378cc87b51cc73907527 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 175 | 162 | 6 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.54e-05 | 176 | 162 | 6 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-05 | 177 | 162 | 6 | 4a697866ed542d3201714234cee03451adf1dcc9 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 4.69e-05 | 177 | 162 | 6 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.99e-05 | 179 | 162 | 6 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-05 | 179 | 162 | 6 | b07ebfd4157ae7436f275add78f2ac9ffc55f417 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 180 | 162 | 6 | 0059e5acade6c895fd629767bea1c15f40b0d1b0 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 180 | 162 | 6 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 180 | 162 | 6 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 180 | 162 | 6 | dfb8412e1e06fa7349e66eea2ef27d9ea98b7893 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.47e-05 | 182 | 162 | 6 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 184 | 162 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-05 | 184 | 162 | 6 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 184 | 162 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 184 | 162 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 185 | 162 | 6 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 185 | 162 | 6 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.17e-05 | 186 | 162 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 187 | 162 | 6 | 74112df9b34051ae5cd2427ccfa3399eccff0076 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-05 | 187 | 162 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 187 | 162 | 6 | 214ce9b55fd6ce2fe7bd4cf4b1383517f5f0d759 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-05 | 187 | 162 | 6 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-05 | 187 | 162 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.55e-05 | 188 | 162 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.74e-05 | 189 | 162 | 6 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | droplet-Bladder|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 190 | 162 | 6 | 170484f7a6f0a0d0792bbe1bb04abad060b7188e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.94e-05 | 190 | 162 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 190 | 162 | 6 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 190 | 162 | 6 | b772a5d281fe016f259ddda80d6f33d949dcac2b | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 6.94e-05 | 190 | 162 | 6 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-05 | 190 | 162 | 6 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 191 | 162 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.15e-05 | 191 | 162 | 6 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 191 | 162 | 6 | b842647caf05d39f602de83c647d5c224715d19f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.15e-05 | 191 | 162 | 6 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 191 | 162 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 192 | 162 | 6 | 18546b4d5e39aafa97186104d47cfda02eb5f4b5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.57e-05 | 193 | 162 | 6 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 193 | 162 | 6 | 268925bfe85fb94a93a4ff8fe078d692df888140 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.57e-05 | 193 | 162 | 6 | 50c2832de75b6469f649355c6b9a75e910d32db3 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 193 | 162 | 6 | ee91a796d0f6d4cee7a93a525689e716fdceeda5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.57e-05 | 193 | 162 | 6 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.57e-05 | 193 | 162 | 6 | 222829c30ebe47f0ed1e035897e3cd4be10b2a11 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 7.79e-05 | 194 | 162 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.79e-05 | 194 | 162 | 6 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.40e-05 | 122 | 162 | 5 | aca079f2f033cc1ac13c4ee02d490b6a514cbd5c | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.40e-05 | 122 | 162 | 5 | ac38130010f76648757eac700a8039f3960ddde3 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.40e-05 | 122 | 162 | 5 | 7ab0b63244116e74c5783c3293cf08224d094d0a | |
| ToppCell | Thalamus-Macroglia-CSF_related|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.40e-05 | 122 | 162 | 5 | eb944243424460bf5c66aced3ed7b7a1b6486ac7 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.40e-05 | 122 | 162 | 5 | 9b0d6b0a394560ff5aadcd3b21519c2393e6def8 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.47e-05 | 197 | 162 | 6 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-05 | 197 | 162 | 6 | b1c6a15bf6c0645952a7247182dc71baf4736869 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.71e-05 | 198 | 162 | 6 | 0f1feed8a37293ae02465909f99548ab58dc7ce5 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.71e-05 | 198 | 162 | 6 | 7608f67959e1cda7b10e57fd3af2f96216ebe7e9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.71e-05 | 198 | 162 | 6 | 96236fa22545f6f4ff3aa8dc002963db8a3468ce | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.71e-05 | 198 | 162 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 8.71e-05 | 198 | 162 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.71e-05 | 198 | 162 | 6 | 9e0fdd63069d17430cdc25bf4ffc762afd5e1728 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.71e-05 | 198 | 162 | 6 | 7eb521af938c2609a85d27e2aa7d4317ad6e1e44 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 8.96e-05 | 199 | 162 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-05 | 199 | 162 | 6 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-05 | 199 | 162 | 6 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | CF-Myeloid-Monocyte_Macrophage|CF / Disease state, Lineage and Cell class | 8.96e-05 | 199 | 162 | 6 | bf95eacb31a4a847350f9d6e95ca76c6b730c400 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-05 | 199 | 162 | 6 | 036776a03fdd181e51cc655ed99331eec9c63f39 | |
| ToppCell | tumor_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.21e-05 | 200 | 162 | 6 | 58ff8db0ecf71daa86f9a38208e0d9b712cac0b5 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.21e-05 | 200 | 162 | 6 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.21e-05 | 200 | 162 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.21e-05 | 200 | 162 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 9.21e-05 | 200 | 162 | 6 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 9.21e-05 | 200 | 162 | 6 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 9.21e-05 | 200 | 162 | 6 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.21e-05 | 200 | 162 | 6 | 4f481d87e30195365900acb5d50641a9e7b2f462 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.21e-05 | 200 | 162 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 9.21e-05 | 200 | 162 | 6 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.21e-05 | 200 | 162 | 6 | cf720d3973e79ffd4c6e763a7284799ced22a274 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.21e-05 | 200 | 162 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; PC3; HT_HG-U133A | RASA3 SPTBN1 IKZF1 HUWE1 RUNX1 PDE10A MINDY2 RYR2 NRP1 CSF1R PDLIM3 | 1.66e-07 | 197 | 161 | 11 | 4668_UP |
| Drug | 855 sigma | 7.65e-07 | 11 | 161 | 4 | CID000074136 | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | 1.27e-06 | 194 | 161 | 10 | 1264_DN | |
| Drug | 1-aminocyclopropane-1-carboxylic acid | 1.53e-06 | 114 | 161 | 8 | CID000000535 | |
| Drug | 2-nitroisocitrate | 5.05e-06 | 62 | 161 | 6 | CID000166578 | |
| Drug | Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.16e-05 | 197 | 161 | 9 | 4847_DN | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.16e-05 | 197 | 161 | 9 | 7383_DN | |
| Drug | UCS15A | 1.31e-05 | 21 | 161 | 4 | CID005311041 | |
| Drug | Topo | 1.36e-05 | 153 | 161 | 8 | CID000065577 | |
| Drug | AC1L9JC0 | 1.92e-05 | 23 | 161 | 4 | CID000446228 | |
| Drug | Fast Red TR | 3.72e-05 | 27 | 161 | 4 | CID000007251 | |
| Drug | Water Pollutants, Chemical | KRT18 IQGAP2 ACP2 ANXA11 E2F7 HMGCS1 PABPC1 GSS AIFM2 PDLIM3 NDC80 DIO2 CTNNB1 C8B ALPL | 4.72e-05 | 635 | 161 | 15 | ctd:D014874 |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 4.93e-05 | 183 | 161 | 8 | 7498_DN | |
| Drug | p-acetaminobenzaldehyde thiosemicarbazone | 6.11e-05 | 59 | 161 | 5 | CID002733749 | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 6.66e-05 | 191 | 161 | 8 | 7507_DN | |
| Drug | ahz | 7.42e-05 | 32 | 161 | 4 | CID000656929 | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 7.43e-05 | 194 | 161 | 8 | 2792_DN | |
| Drug | p-nitrophenyl phosphate | 7.43e-05 | 194 | 161 | 8 | CID000000378 | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 7.98e-05 | 196 | 161 | 8 | 5827_DN | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; HL60; HT_HG-U133A | 7.98e-05 | 196 | 161 | 8 | 1346_UP | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; PC3; HT_HG-U133A | 8.27e-05 | 197 | 161 | 8 | 3666_UP | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 8.27e-05 | 197 | 161 | 8 | 1698_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 2065_UP | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 7366_DN | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; HL60; HG-U133A | 8.57e-05 | 198 | 161 | 8 | 1380_UP | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 3670_UP | |
| Drug | Bisoprolol fumarate; Down 200; 9uM; HL60; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 1287_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 7313_UP | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 8.57e-05 | 198 | 161 | 8 | 2791_UP | |
| Drug | Metyrapone [54-36-4]; Up 200; 17.6uM; PC3; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 4606_UP | |
| Drug | Pentoxifylline [6493-05-6]; Up 200; 14.4uM; PC3; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 7319_UP | |
| Drug | Artemisinin [63968-64-9]; Down 200; 14.2uM; HL60; HG-U133A | 8.87e-05 | 199 | 161 | 8 | 1714_DN | |
| Drug | retinoic acid; Up 200; 1uM; PC3; HT_HG-U133A | 8.87e-05 | 199 | 161 | 8 | 4435_UP | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; HL60; HG-U133A | 9.19e-05 | 200 | 161 | 8 | 1720_DN | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 3.99e-05 | 13 | 156 | 3 | C3501611 | |
| Disease | hereditary spherocytosis type 1 (implicated_via_orthology) | 1.65e-04 | 4 | 156 | 2 | DOID:0110916 (implicated_via_orthology) | |
| Disease | Precursor B-cell lymphoblastic leukemia | 1.80e-04 | 21 | 156 | 3 | C1292769 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 2.75e-04 | 5 | 156 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Pachyonychia Congenita | 2.75e-04 | 5 | 156 | 2 | C0265334 | |
| Disease | Hereditary spherocytosis | 2.75e-04 | 5 | 156 | 2 | cv:C0037889 | |
| Disease | ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2 | 2.75e-04 | 5 | 156 | 2 | C1832931 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 2.75e-04 | 5 | 156 | 2 | C0221409 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.10e-04 | 61 | 156 | 4 | C1961102 | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.45e-04 | 67 | 156 | 4 | C3463824 | |
| Disease | invasive lobular carcinoma (is_marker_for) | 5.73e-04 | 7 | 156 | 2 | DOID:3457 (is_marker_for) | |
| Disease | Acute lymphocytic leukemia | 5.73e-04 | 7 | 156 | 2 | C0023449 | |
| Disease | Hereditary spherocytosis | 7.62e-04 | 8 | 156 | 2 | C0037889 | |
| Disease | N2,N2-dimethylguanosine measurement | 7.62e-04 | 8 | 156 | 2 | EFO_0021125 | |
| Disease | Burkitt Lymphoma | 9.11e-04 | 36 | 156 | 3 | C0006413 | |
| Disease | stomach cancer (is_marker_for) | 9.70e-04 | 142 | 156 | 5 | DOID:10534 (is_marker_for) | |
| Disease | insulin response measurement | 9.76e-04 | 9 | 156 | 2 | EFO_0008473 | |
| Disease | aspartate aminotransferase measurement | TNPO1 IQGAP2 ZC3H8 NSD1 RNF213 IKZF1 ATP8B1 STN1 GSS WDR91 CSF1R PUM3 CTNNA2 | 1.07e-03 | 904 | 156 | 13 | EFO_0004736 |
| Disease | mean reticulocyte volume | TNPO1 ANK1 IQGAP2 IKZF1 RUNX1 TRRAP REXO1 STN1 LDB2 AFF1 TNFAIP8 CDH6 | 1.15e-03 | 799 | 156 | 12 | EFO_0010701 |
| Disease | Alzheimer disease, polygenic risk score | ZNF229 RUNX2 MINDY2 NRP1 CTNNA3 SCAPER CTNNA1 SLC2A13 EPB42 ALPL | 1.17e-03 | 586 | 156 | 10 | EFO_0030082, MONDO_0004975 |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.22e-03 | 10 | 156 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 1.69e-03 | 616 | 156 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.69e-03 | 616 | 156 | 10 | C0376358 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.77e-03 | 12 | 156 | 2 | C0023485 | |
| Disease | Leukemia, Myelocytic, Acute | 2.31e-03 | 173 | 156 | 5 | C0023467 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 2.37e-03 | 50 | 156 | 3 | C0023453 | |
| Disease | femoral neck bone geometry | 2.42e-03 | 14 | 156 | 2 | EFO_0004511 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 2.65e-03 | 52 | 156 | 3 | C0023452 | |
| Disease | total blood protein measurement | 2.77e-03 | 449 | 156 | 8 | EFO_0004536 | |
| Disease | migraine disorder | 2.99e-03 | 357 | 156 | 7 | MONDO_0005277 | |
| Disease | gout, hyperuricemia | 3.17e-03 | 16 | 156 | 2 | EFO_0004274, EFO_0009104 | |
| Disease | hippocampal atrophy | 3.27e-03 | 56 | 156 | 3 | EFO_0005039 | |
| Disease | platelet-to-lymphocyte ratio | 3.28e-03 | 363 | 156 | 7 | EFO_0008446 | |
| Disease | Drug habituation | 3.30e-03 | 115 | 156 | 4 | C0013170 | |
| Disease | Drug abuse | 3.30e-03 | 115 | 156 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.30e-03 | 115 | 156 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.30e-03 | 115 | 156 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.30e-03 | 115 | 156 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.30e-03 | 115 | 156 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.30e-03 | 115 | 156 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.30e-03 | 115 | 156 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.30e-03 | 115 | 156 | 4 | C0029231 | |
| Disease | Substance abuse problem | 3.40e-03 | 116 | 156 | 4 | C0740858 | |
| Disease | Acute Myeloid Leukemia, M1 | 4.44e-03 | 125 | 156 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 4.44e-03 | 125 | 156 | 4 | C1879321 | |
| Disease | carcinoma (implicated_via_orthology) | 4.77e-03 | 64 | 156 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Familial aplasia of the vermis | 4.96e-03 | 20 | 156 | 2 | cv:C0431399 | |
| Disease | brain age measurement | 4.96e-03 | 20 | 156 | 2 | EFO_0010602 | |
| Disease | PR interval | 4.97e-03 | 495 | 156 | 8 | EFO_0004462 | |
| Disease | peak expiratory flow | 5.14e-03 | 498 | 156 | 8 | EFO_0009718 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QDSQNVEALRMQALY | 241 | Q7Z4L5 | |
| ENLQENSQEVGTYML | 401 | Q9BYV1 | |
| MNYLEVNRRVNNFGS | 126 | O60488 | |
| NEAQRMEYLLNQNGL | 151 | P16452 | |
| QRIQEQGVEYQAAME | 3066 | Q99996 | |
| RMLYDAQLSEEQGRN | 3281 | Q99996 | |
| NVDMSLAQRDAQELY | 351 | P50995 | |
| NVGVAQAYMNQRKLD | 71 | P78537 | |
| ADDMQIRVFNYNTLE | 76 | P35606 | |
| LQSQFYNLVMENREA | 301 | Q96DY2 | |
| RAEEMQENYQRNGTA | 6 | Q2M3G0 | |
| NNNVQSMRRTEELIY | 1356 | Q12774 | |
| IREGQNANMENLYTA | 1456 | P16157 | |
| DEDQLMYRLSYQVQG | 366 | Q9UK96 | |
| NILDNLLSRMEQYAN | 811 | P16066 | |
| DDYQERMNKGERLNQ | 76 | Q14444 | |
| AMNNLSENYENQGRL | 451 | Q7L311 | |
| LQGYNDSLQEEMNVD | 186 | Q9UN42 | |
| TVMVDRTDGQLNYQA | 536 | O43520 | |
| TVVQNLMERNNLSYD | 71 | Q01581 | |
| QDLASMINVEYLNGS | 76 | Q96L73 | |
| ENLENNMENLRQYVD | 421 | Q14644 | |
| EQRNMLTEELYGNTF | 266 | Q15397 | |
| QRMRVQDDGGSDQNY | 341 | Q96PE3 | |
| GNDVYDVMLNQTNLQ | 111 | Q9UGN5 | |
| EQMKQDRITRYQGVN | 281 | P11940 | |
| LNNMRAEYEDLAEQN | 256 | Q7Z3Y9 | |
| LQNMAEEIIDGSYLN | 36 | Q7RTW8 | |
| LNFTITNLQYEENMG | 13171 | Q8WXI7 | |
| QEQVADIDGQYAMTR | 76 | P35222 | |
| LGGAMENQDIAANYR | 151 | Q9Y4B6 | |
| VADRMDNNANIAYGV | 211 | Q92813 | |
| EVEARYALQMEQLNG | 326 | P05783 | |
| GVDLTQLLNNMRSQY | 311 | P13645 | |
| AEDQRQLYAMANTLE | 101 | A8MTJ3 | |
| NRLNLEAINYMAADG | 111 | P09382 | |
| RMNGDQNSDVYAQEK | 66 | P14324 | |
| EIRMYDAQQQQVGTN | 791 | Q07954 | |
| LNNAVALDFDYREQM | 3056 | Q07954 | |
| QQEANMDRPIAGYAN | 236 | Q96KR4 | |
| TRLENTQYDAANGMD | 321 | O43679 | |
| DAQDLDTMQRLNIGY | 336 | Q9Y6W6 | |
| MEEQYNQYQVNGERL | 686 | P0DPD6 | |
| YSTVMEQQVNGQLIE | 86 | Q13163 | |
| LANGQMNEQDIRYRD | 156 | Q13163 | |
| NRKQLEEMYQTGSLN | 631 | Q9Y233 | |
| EQYLQLDLNMSLGQR | 516 | Q6NT32 | |
| NLQTYLQEEDTRMQQ | 2236 | Q6KC79 | |
| LAQLRCEMEQQSQEY | 386 | P08779 | |
| NDYVNMTGLDLSAIQ | 266 | Q8IWV1 | |
| EQTLYQVQERMAGAE | 1636 | P55268 | |
| SLQQNLQRDYDRAMS | 411 | Q1ED39 | |
| QLDQELRGYMNREEN | 1006 | Q8TDZ2 | |
| MDQAINNAINYLGAE | 311 | Q13422 | |
| QDIDAQMDYQLRLQG | 361 | Q8N594 | |
| VGQLLQDMGDDVYQQ | 1976 | Q7Z6Z7 | |
| VQQRNELGVYLMNLS | 46 | P46093 | |
| NMRFQVQIGLEDYIN | 261 | Q14541 | |
| QMIDGDLQANQAVYN | 631 | Q86UA1 | |
| SEQLDVAGRVMQYVN | 701 | Q6VY07 | |
| EAQVYLALGDQMLNA | 251 | P32942 | |
| VNALLDNGTRYNMLN | 586 | Q6ZMV5 | |
| DNGTRYNMLNSAILE | 591 | Q6ZMV5 | |
| NGMSERNLSALENYN | 886 | O14786 | |
| VALQMALDVYNGEQA | 291 | P11117 | |
| EPGDMQYELNRNNVT | 291 | P05186 | |
| RSLLSAQQYQEMEGN | 606 | Q7Z3G6 | |
| YDEAIMAQQDRIQQE | 26 | Q96FW1 | |
| RQALQDLLSEYMNNA | 336 | Q9UI47 | |
| TVENLQYMLNNISGD | 3136 | Q9P2D7 | |
| RDIMNDSNYIVKGNA | 801 | P07333 | |
| YVIGENRQVSQDLMQ | 286 | Q7L8L6 | |
| INANDQAIAYVMLGN | 1161 | P54132 | |
| ALQGDMEQALENYDI | 626 | Q9Y6J0 | |
| NLQRLGEEQKYEEQM | 221 | Q96AV8 | |
| ALQDLLSEYMNNTGR | 341 | P26232 | |
| RQALQDLLSEYMGNA | 341 | P35221 | |
| NEQVQIQAMLYNFRD | 81 | Q6ZMU1 | |
| EVYTRLGEMNNAVRN | 491 | Q8NHQ1 | |
| RYCMGNQEVSLENQQ | 246 | Q5THR3 | |
| ENNDFNTLSGMLRYI | 1416 | Q5T9S5 | |
| KNSNQLREYQLEGMN | 456 | Q8TD26 | |
| ESLRMQLLDYQAQSD | 1181 | O15078 | |
| NQQAREQVERGYRMS | 766 | P16591 | |
| QGILDRIYASQTDQM | 306 | Q8WUX9 | |
| NRGIAQMLEKYQQGD | 91 | P67870 | |
| MNIALEQTEEYVNGQ | 41 | P62312 | |
| MLNTLQTNAGYLEQV | 51 | Q05932 | |
| LLNMDRENREQYQVV | 221 | P55285 | |
| QQELNQMGKAFYVER | 86 | Q5VU69 | |
| QRQEQYLQEGQEQMS | 821 | A6NE01 | |
| GNNLYGEEMVQALKQ | 371 | P48637 | |
| NNRVQDLISYVVNMG | 1096 | Q9BY12 | |
| EQERNYNLQMSLETL | 926 | Q92736 | |
| NKEAMERGDYTLNNV | 361 | P07358 | |
| ERQEQEDYQEMLQSL | 1221 | Q9HAU5 | |
| VNMYNRLRATGEDEN | 31 | Q99574 | |
| QSIEYADEQGQMQLS | 46 | O14829 | |
| EMRNAIENLLGYQSG | 291 | P0C604 | |
| QMRGNQTIDEEYDSI | 281 | Q96QE2 | |
| FEEEQNLRGNLTNME | 371 | P32754 | |
| ISEIQRLNYEQNMSD | 311 | Q8NBR6 | |
| QIDQDYLMALSLQQE | 511 | Q8NBR6 | |
| MAGNDENYSAELRNA | 106 | Q01196 | |
| VMAGNDENYSAELRN | 156 | Q13950 | |
| MADYLRQIIQDNVDG | 1181 | Q8N1G1 | |
| SNGIIQSYRLQRNEM | 4291 | O75445 | |
| LQVNRAYNENDVILM | 901 | A5PLK6 | |
| RQMNENFPENVNYED | 711 | Q9Y3M8 | |
| AGGNQMLEQYDKLQD | 186 | P22061 | |
| LMENRVQSFYQQELE | 216 | Q9H668 | |
| NLREIQDDMQTLYVN | 391 | A6NHR9 | |
| QAAIQAYEDMVRQVQ | 126 | Q9BRQ8 | |
| DMLLQAQGSFQELYQ | 486 | Q58EX7 | |
| ITAMEEAALYGNVQQ | 636 | Q587J7 | |
| NIQDLLQMQYEGVAV | 1536 | Q13576 | |
| SEQRAMLAQQYQEGT | 521 | P58107 | |
| IAMRTGNYIELNEEN | 391 | Q5U5Q3 | |
| AMYQEELGGQRDLVQ | 476 | Q6ZNE9 | |
| MGNIVAANLNESYDI | 486 | Q07837 | |
| ENQVLGQYIENLMSA | 131 | Q9UIL1 | |
| LYSDDNIMETLQGQV | 196 | Q53GG5 | |
| YRNNQFNQDELALME | 86 | O95379 | |
| ELQELYEGLRLNNMN | 61 | O00764 | |
| MADERRDQLEQYLQN | 71 | Q8N9S9 | |
| GQTDAQYMFLRQRLQ | 1131 | Q01082 | |
| DELSSRIQNMLGNYE | 51 | P51825 | |
| QALQVMYDAGQAKQE | 686 | Q96JN2 | |
| ELQLQYQASMDEQGR | 931 | Q96JN2 | |
| NILAQDLMQQSSELY | 251 | Q9UNK9 | |
| QYQRDTEQLRRSMQD | 521 | Q9P2M7 | |
| VMQRNYLQGENENRT | 56 | Q9P126 | |
| ENVTQYLRYNQEELM | 141 | Q15596 | |
| QAQGLAMYLQENGID | 856 | Q96EP0 | |
| ATGAMRNLIYDNADN | 381 | Q9Y446 | |
| DSLFQILSERQDMYQ | 131 | Q8NB15 | |
| LNVYTQDILQMGDQT | 5046 | Q63HN8 | |
| LDTAQQNLYRNVMLE | 21 | A8MTY0 | |
| SQIEELSDNIQQYLM | 166 | Q6NUQ1 | |
| VALNYQSEGRMLQLN | 706 | O75038 | |
| LDTAQQNLYRNVMLE | 21 | P0DKX0 | |
| LMNLQNNEAGRRAVY | 196 | Q9H1J7 | |
| NTQRQYEAERNKMIG | 246 | Q8WVM7 | |
| ALLQQEAETMAEQGY | 471 | Q9BT92 | |
| VEYMLQRTQDQDENV | 266 | Q92973 | |
| NMQLANTEEYIDGAL | 41 | P62306 | |
| QYRGNEGQMRELQDQ | 831 | Q13464 | |
| LDTEQQNLYRNVMLD | 21 | Q6ZMV8 | |
| LDSTQRQLYQDVMQE | 51 | Q9UJW7 | |
| IDNQMDRYQGNQDRV | 121 | Q2M218 | |
| VMLENYRNLASVADQ | 231 | Q96JL9 | |
| LNQGQSYEIRMLDNR | 86 | Q9NZI7 | |
| LDTAQQNLYRNVMLE | 21 | P17019 | |
| LDTAQQNLYRNVMLE | 21 | O43345 | |
| EADQRGLYQEVMQEN | 176 | A6NFI3 | |
| LDTAQQNLYRNVMLE | 21 | Q86V71 | |
| QEYGLLQRRLENMEN | 246 | Q9ULD5 | |
| DVVQQNNTLIEEMLY | 741 | Q8IWV8 | |
| YDIRELQAMEALQNG | 161 | Q9C0B0 | |
| VDQLQQLMQVYDLAA | 46 | A4D1P6 | |
| DTAQQNLYRDVMLEN | 31 | Q96H40 | |
| AMQALDIYQVQIAGN | 596 | Q9Y4A5 | |
| IQNDRQLQYERDMVV | 336 | Q9UBB9 | |
| QQLDSTQRRLYQDVM | 36 | P51508 | |
| DTVQQNLYRDVMLEN | 31 | A6NN14 | |
| QYIQAREMANAAQPE | 96 | Q8N5P1 | |
| ESMEQNAGQLDDQYI | 446 | Q96M32 | |
| MQELRSQDVNKQGLY | 16 | O14777 |